TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LEGEND BIOTECH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

LEGEND BIOTECH

ST13

US500000097446452

Classe

5, 42, 44

Pedido

97446452

Registro

7283305

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

09/07/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 42, 44

Data de depósito

07/06/2022

Data de registro

23/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/01/2024

Última transação

09/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Primeiro uso

2018-12-00

Primeiro uso no comércio

2018-12-00

Código do desenho

3

Tipo de titular

03

Localização do titular

Bridgewater, NJ, US

Examinador

LORENZO, KATHLEEN H

Unidade examinadora

L90

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the wording "LEGEND" above the wording "BIOTECH," both in stylized form and to the right of a wavy line forming the letters "L" and "B".

Titulares e representantes

Titulares

LEGEND BIOTECH USA INC.
Nanjing Legend Biotech Co., Ltd.

Representantes

Preetha Chakrabarti Crowell & Moring LLP

Classificação técnica

Classes Nice

Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations

Classe 42

Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming

Classe 44

Medical services; alternative medicine services; cultured cell bank services for medical transplantation; health care; health centre services; health counselling; health assessment services; hospital services; medical advice for individuals with disabilities; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical clinic services; medical treatment using cultured cells; preparation of prescriptions by pharmacists; therapy services, namely, immunotherapy, cell therapy, gene therapy, antibody therapy, radiation therapy, or chemotherapy; Medical services relating to the removal, treatment and processing of human cells; Providing cancer screening services; Medical services for the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for cancer diagnosis and prognosis; Medical screening; provision of medical information; stem cell therapy services

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/07/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/07/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/07/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/07/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/07/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

17/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

23/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

23/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/11/2023

PUBO

PUBLISHED FOR OPPOSITION

07/11/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/09/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

25/09/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

25/09/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

25/09/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/09/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

25/09/2023

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

20/06/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

20/06/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

29/03/2023

GNRT

NON-FINAL ACTION E-MAILED

29/03/2023

CNRT

NON-FINAL ACTION WRITTEN

29/03/2023

DOCK

ASSIGNED TO EXAMINER

22/03/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

17/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/06/2022

NWAP

NEW APPLICATION ENTERED

10/06/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LEGEND BIOTECH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.